Systolic heart failure
Myocardial-infarction-based studies for programs targeting a systolic heart-failure context.
CARDIOVASCULAR MODEL
Rat Heart Failure Models
Documented rat heart-failure platforms include myocardial-infarction systolic heart failure and abdominal- or aortic-arch-constriction diastolic heart-failure models.
Heart-failure phenotype, induction approach, treatment window, functional assessment, tissue collection, and biomarker package are aligned per study.
MODEL OVERVIEW
Complementary rat models for systolic and diastolic heart-failure research.
Partner documentation identifies myocardial-infarction and pressure-overload approaches for heart-failure pharmacology. The specific model is selected around the intended disease phenotype and development question.
Therapeutic areaHeart failure
SpeciesRat
Model formatMI, aortic constriction
Typical useEfficacy, Functional phenotyping
TYPICAL APPLICATIONS
What this model can support.
Diastolic heart failure
Pressure-overload models using abdominal or aortic-arch constriction for diastolic heart-failure research.
Treatment-response studies
Compare candidate and reference treatment arms using protocol-defined cardiovascular assessments.
Biomarker & tissue integration
Combine efficacy assessment with fit-for-purpose biomarkers and cardiac tissue analysis when required.
COMMON READOUTS
Readouts selected around the study question.
Endpoints are finalized with the selected model, species or strain, treatment design, and partner laboratory before study placement.
Cardiac function
Protocol-defined functional measurements appropriate to the selected heart-failure model.
Clinical observations
Body weight, general observations, and model-specific in-life measurements.
Biomarkers
Protocol-defined circulating or tissue biomarkers selected for the candidate mechanism.
Pathology
Cardiac tissue collection and histopathology when included in the study plan.
Exact surgical method, model-entry criteria, functional readouts, treatment window, and tissue package are confirmed during technical review.
STUDY DESIGN
Key factors aligned before execution.
- Systolic or diastolic disease context
- Myocardial-infarction or constriction approach
- Study entry and treatment window
- Functional assessment schedule
- Biomarker and pathology plan
- PK/PD integration requirements
Discuss Your Program
Share the compound, mechanism, development question, preferred model, and intended endpoints. We can review fit, feasibility, and the appropriate partner-laboratory route for a Heart Failure study.Required fields are marked with an asterisk(*).